Semler Scientific expects Q2 revenues will be the highest quarterly revenues in its history, driven by continued sales of QuantaFlo to existing and new customers to test for peripheral arterial disease. The company expects to provide more detailed financial information in the Q2 earnings release on or around August 10.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SMLR:
